VIRTUAL SCREENING STATEGIES IN DRUG DISCOVERY – A BRIEF OVERVIEW
Keywords:virtual screening, drug discovery, molecular docking, drug-likeness, ADME
AbstractComputer-aided drug design has now become a compulsory tool in the drug discovery and development process which uses computational approaches to discover potential compounds with expected biological activities. Firstly, this review provides a comprehensive introduction of the virtual screening technique, knowledge and advances in both SBVS and LBVS strategies also presented. Secondly, recent database of compounds provided worldwide and drug-like parameters which are helpful in supporting the VS process will be discussed. These information will provides a good platform to estimate the advance of applying these techniques in the new drug-lead identification and optimization.
Do Tat, L. and D. Nguyen Xuan, Native drugs of Vietnam: which traditional and scientific approaches? Journal of Ethnopharmacology, 1991. 32(1-3): p. 51-56.
Dias, D.A., S. Urban, and U. Roessner, A Historical Overview of Natural Products in Drug Discovery. Metabolites, 2012. 2(2): p. 303-336.
Newman, D.J., G.M. Cragg, and K.M. Snader, Natural Products as Sources of New Drugs over the Period 1981−2002. Journal of Natural Products, 2003. 66(7): p. 1022-1037.
Pan, S.-Y., et al., New Perspectives on How to Discover Drugs from Herbal Medicines: CAM's Outstanding Contribution to Modern Therapeutics. Evidence-Based Complementary and Alternative Medicine, 2013. 2013: p. 1-25.
Sliwoski, G., et al., Computational Methods in Drug Discovery. Pharmacological Reviews, 2013. 66(1): p. 334-395.
Réda, C., E. Kaufmann, and A. Delahaye-Duriez, Machine learning applications in drug development. Computational and Structural Biotechnology Journal, 2020. 18: p. 241-252.
Ooms, F., Molecular Modeling and Computer Aided Drug Design. Examples of their Applications in Medicinal Chemistry. Current Medicinal Chemistry, 2000. 7(2): p. 141-158.
Gasteiger, J., Chemoinformatics: a new field with a long tradition. Analytical and Bioanalytical Chemistry, 2005. 384(1): p. 57-64.
Downs, G.M. and J.M. Barnard, Clustering Methods and Their Uses in Computational Chemistry, in Reviews in Computational Chemistry, Volume 18. 2002. p. 1-40.
Song, C.M., S.J. Lim, and J.C. Tong, Recent advances in computer-aided drug design. Briefings in Bioinformatics, 2009. 10(5): p. 579-591.
Yu, W. and A.D. MacKerell, Computer-Aided Drug Design Methods, in Antibiotics. 2017. p. 85-106.
Singh, B.K. and S. Surabhi, Computer Aided Drug Design: An Overview. Journal of Drug Delivery and Therapeutics, 2018. 8(5): p. 504-509.
da Silva Rocha, S.F.L., et al., Virtual Screening Techniques in Drug Discovery: Review and Recent Applications. Current Topics in Medicinal Chemistry, 2019. 19(19): p. 1751-1767.
Slater, O. and M. Kontoyianni, The compromise of virtual screening and its impact on drug discovery. Expert Opinion on Drug Discovery, 2019. 14(7): p. 619-637.
Kontoyianni, M., Docking and Virtual Screening in Drug Discovery, in Proteomics for Drug Discovery. 2017. p. 255-266.
Paul, S.M., et al., How to improve R&D productivity: the pharmaceutical industry's grand challenge. Nature Reviews Drug Discovery, 2010. 9(3): p. 203-214.
Kale, V.P., et al., Old drugs, new uses: Drug repurposing in hematological malignancies. Seminars in Cancer Biology, 2021. 68: p. 242-248.
Tamimi, N.A.M. and P. Ellis, Drug Development: From Concept to Marketing! Nephron Clinical Practice, 2009. 113(3): p. c125-c131.
Moridani, M. and S. Harirforoosh, Drug development and discovery: challenges and opportunities. Drug Discovery Today, 2014. 19(11): p. 1679-1681.
Jacq, N., et al., Grid-enabled Virtual Screening Against Malaria. Journal of Grid Computing, 2007. 6(1): p. 29-43.
Kasam, V., et al., WISDOM-II: Screening against multiple targets implicated in malaria using computational grid infrastructures. Malaria Journal, 2009. 8(1).
de Beer, T.A.P., et al., Antimalarial Drug Discovery: In Silico Structural Biology and Rational Drug Design. Infectious Disorders - Drug Targets, 2009. 9(3): p. 304-318.
Ton, A.T., et al., Rapid Identification of Potential Inhibitors of SARS‐CoV‐2 Main Protease by Deep Docking of 1.3 Billion Compounds. Molecular Informatics, 2020. 39(8).
Rutwick Surya, U. and N. Praveen, A molecular docking study of SARS-CoV-2 main protease against phytochemicals of Boerhavia diffusa Linn. for novel COVID-19 drug discovery. VirusDisease, 2021.
Soumia, M., et al., Towards potential inhibitors of COVID-19 main protease Mpro by virtual screening and molecular docking study. Journal of Taibah University for Science, 2020. 14(1): p. 1626-1636.
Talluri, S., Molecular Docking and Virtual Screening based prediction of drugs for COVID-19. Combinatorial Chemistry & High Throughput Screening, 2020. 23.
Keretsu, S., S.P. Bhujbal, and S.J. Cho, Rational approach toward COVID-19 main protease inhibitors via molecular docking, molecular dynamics simulation and free energy calculation. Scientific Reports, 2020. 10(1).
Ngo, S.T., et al., Assessing potential inhibitors of SARS-CoV-2 main protease from available drugs using free energy perturbation simulations. RSC Advances, 2020. 10(66): p. 40284-40290.
Pham, M.Q., et al., Rapid prediction of possible inhibitors for SARS-CoV-2 main protease using docking and FPL simulations. RSC Advances, 2020. 10(53): p. 31991-31996.
Pranav Kumar, S.K. and V.M. Kulkarni, Molecular dynamics simulations of the three dimensional model of plasmepsin II-peptidic inhibitor complexes. Drug Des Discov, 2001. 17(4): p. 293-313.
Dong, G.Q., et al., Prediction of Substrates for Glutathione Transferases by Covalent Docking. Journal of Chemical Information and Modeling, 2014. 54(6): p. 1687-1699.
Choowongkomon, K., et al., Computational analysis of binding between malarial dihydrofolate reductases and anti-folates. Malaria Journal, 2010. 9(1).
Liu, Z., et al., Molecular Docking of Potential Inhibitors for Influenza H7N9. Computational and Mathematical Methods in Medicine, 2015. 2015: p. 1-8.
Chenafa, H., et al., In silico design of enzyme α-amylase and α-glucosidase inhibitors using molecular docking, molecular dynamic, conceptual DFT investigation and pharmacophore modelling. Journal of Biomolecular Structure and Dynamics, 2021: p. 1-22.
Basu, A., A. Sarkar, and U. Maulik, Molecular docking study of potential phytochemicals and their effects on the complex of SARS-CoV2 spike protein and human ACE2. Scientific Reports, 2020. 10(1).
Du, X., et al., Insights into Protein–Ligand Interactions: Mechanisms, Models, and Methods. International Journal of Molecular Sciences, 2016. 17(2).
Muegge, I. and S. Oloff, Advances in virtual screening. Drug Discovery Today: Technologies, 2006. 3(4): p. 405-411.
Reddy, A.S., et al., Virtual Screening in Drug Discovery - A Computational Perspective. Current Protein & Peptide Science, 2007. 8(4): p. 329-351.
Kuntz, I.D., et al., A geometric approach to macromolecule-ligand interactions. Journal of Molecular Biology, 1982. 161(2): p. 269-288.
Jones, G., et al., Development and validation of a genetic algorithm for flexible docking 1 1Edited by F. E. Cohen. Journal of Molecula